Patent · US Active

Methods of maintaining, treating or improving cognitive function

US9585877B2 · kind B2 · utility

0Cited by

58References

40Claims

0Family size

Assignee

Forum Pharmaceuticals, Inc. · US

Inventors

Dana Hilt · Waltham, US
Gerhard Koenig · Newton, US

Key dates

Filing date	May 6, 2013
Grant date	Mar 7, 2017
Priority date	—
Expiry date	May 6, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of administering an effective amount of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.